Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

acrocyte logo final

Acrocyte Therapeutics

Clinically adaptable platform that can generate single cell derived organoids with unprecedented speed
2021
11-50
Taipei, T’ai-pei, Taiwan

Investment Funding

Last Funding Stage

Venture - Series Unknown

Last Funding Date

01-02-2023

Lead Investors

Darwin Venture Management

People

Founders

Something missing or incorrect on this page? Help us enrich this information